The findings of a surgical hip fracture trial were generalisable to the UK national hip fracture database
dc.contributor.author | Lee, H | |
dc.contributor.author | Cook, JA | |
dc.contributor.author | Lamb, SE | |
dc.contributor.author | Parsons, N | |
dc.contributor.author | Keene, DJ | |
dc.contributor.author | Sims, AL | |
dc.contributor.author | Costa, ML | |
dc.contributor.author | Griffin, XL | |
dc.date.accessioned | 2020-11-23T16:31:39Z | |
dc.date.issued | 2020-12-03 | |
dc.description.abstract | Objective: To estimate the generalisability of treatment effects observed in a randomised trial of hip fracture surgery implants, to a broader population of people undergoing hip surgery in the United Kingdom. Study Design and Setting: In 2018, the WHiTE-3 trial (n=958) demonstrated that a modular hemiarthroplasty implant conferred no additional benefit over the traditional monoblock implant for quality of life and length of hospital stay. We compared and weighted the trial sample against two target populations: WHiTE-cohort (n=2,457) and UK-National Hip Fracture Database (NHFD, n=190,894), and re-estimate expected treatment effects for the target populations. Results: Despite differences in baseline characteristics of the trial sample and target populations, the reestimated treatment effects were comparable. For quality of life, the differences between the trial estimate and WHiTE-cohort and NHFD estimates were 0.01 points on the EuroQol (EQ5D). For length of stay, the difference between the trial estimate and WHiTE-cohort was 0.50 days; and the difference between the trial estimate and NHFD estimate was -0.47 days. Conclusion: This generalisability analysis of the WHiTE-3 trial found that the inferences from the trial can be generalised to the group of individuals in the UK NHFD and the WHiTE-cohort who met the inclusion criteria for WHiTE-3. | en_GB |
dc.identifier.citation | Published online 3 December 2020 | en_GB |
dc.identifier.doi | 10.1016/j.jclinepi.2020.11.016 | |
dc.identifier.uri | http://hdl.handle.net/10871/123737 | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.rights.embargoreason | Under embargo until 3 December 2021 in compliance with publisher policy | en_GB |
dc.rights | © 2020. This version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dc.subject | External validity | en_GB |
dc.subject | generalizability | en_GB |
dc.subject | hip fracture | en_GB |
dc.subject | surgery | en_GB |
dc.title | The findings of a surgical hip fracture trial were generalisable to the UK national hip fracture database | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2020-11-23T16:31:39Z | |
dc.identifier.issn | 0895-4356 | |
dc.description | This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this record | en_GB |
dc.identifier.journal | Journal of Clinical Epidemiology | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dcterms.dateAccepted | 2020-11-23 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2020-11-23 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2020-11-23T16:03:32Z | |
refterms.versionFCD | AM | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2020. This version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/